OLIG2 Recombinant Monoclonal Antibody

1. indicate Olig2 as an onco-requisite factor in diffuse intrinsic pontine glioma PMID: 28339768
2. OLIG2 immunoreactivity was observed in GABAergic cells of the proliferative zones of the MGE and septum, but not necessarily co-expressed with NKX2.1, and OLIG2 expression was also extensively seen in the LGE, CGE, and cortex PMID: 27905023
3. Data suggest positive feedback loops including oligodendrocyte transcription factor 2 (OLIG2): loops of epigenetic regulation. PMID: 27447975
4. Data show that oligodendrocyte transcription factor 2 (OLIG2) is epigenetically regulated via DNA methylation and expressed in a subset of AML patients. PMID: 28760688
5. Ectopic expression of phosphomimetic Olig2 is sufficient to block TGF-beta2-mediated invasion. PMID: 27396340
6. phosphorylation of the motif itself serves as a template to prime phosphorylation of additional serines and creates a highly charged "acid blob" in the amino terminus of Olig2. PMID: 28355568
7. Olig2 was expressed in cord blood eosinophils on d 24, when cord blood eosinophils are considered fully differentiated, but no earlier. It was also expressed in human peripheral-blood eosinophils but not neutrophils, monocytes, lymphocytes, or cord blood mast cells. Many genes, including eosinophil surface molecules, were up-regulated along with OLIG2. OLIG2 shRNA or siRNA downregulated SIGLEC-8 mRNA and protein. PMID: 27154355
8. Data indicate that transcription factors Sox10 and Olig2 play key roles in oligodendrocytes (OLs) specification. PMID: 27785726
9. Olig2 expressions were successfully detected in 12 (15.58%) of 77 SVZ type II Glioblastomas (GBs) and 16 (21.3%) of 75 SVZ type III GBs. PMID: 27179219
10. Olig2 was positive in 5 out of 44 ependymomas (11%) and 50 out of 54 (93%) non-ependymal tumors PMID: 26287936
11. The present study is the first to verify the associations of SNPs rs762178, rs1059004, and rs9653711 of the OLIG2 gene with OCD in a Chinese Han population. Thus, OLIG2 might serve as a potential target for OCD treatment PMID: 26271930
12. The results demonstrate that the expression of Olig2 in dental pulp stem cells reduces the expression of stem cell markers and induces the development of oligodendrocyte progenitors. PMID: 25966902
13. High Olig2 expression is associated with oligodendrogliomas. PMID: 25085214
14. OLIG2 is the most specific GSC marker. PMID: 25384509
15. Our study suggests that CGT expression is controlled by balanced expression of the negative modulator OLIG2 and positive regulator Nkx2.2, providing new insights into how expression of GalCer is tightly regulated in cell-type- and stage-specific manners. PMID: 24821492
16. Authors investigated the role of Pten in these two critical cellular compartments in adult and developing brains using methods for activation or suppression of PI3K signaling in glial and neuronal progenitors expressing Olig2. PMID: 24395742
17. LGR5 expression may be functionally correlated with the neurogenic competence, and be regulated by OLIG2 in stem-like cells in glioblastoma. PMID: 23793848
18. We found that the risk allele OLIG2 (A) was associated with reduced white matter integrity in the corona radiata bilaterally PMID: 22505278
19. Olig2-positive cells in glioneuronal tumors, and some of them also exhibited neuronal features PMID: 23025580
20. Report role of OLIG2 immunostaining pattern in diagnosing rare and glioblastoma variants. PMID: 23041832
21. This study review OLIG2 have developmental functions in patterning, neuron subtype specification and the formation of oligodendrocytes and play the role in the postnatal brain during repair processes and in neurological disease states. PMID: 23165259
22. OLIG2 over-expression inhibits neural progenitor proliferation through changes in potassium channel activity, thereby contributing to the reduced neuronal numbers and brain size in DS. PMID: 22343408
23. Nogo-A is more useful and specific than Olig-2 in differentiating oligodendrogliomas from other gliomas. PMID: 21835431
24. Olig2 expression is restricted to isolation and during membrane production of regenerating oligodendrocyte cultures isolated from white matter of medically intractable epilepsy patients. PMID: 21446039
25. The Olig2 can induce desired neuronal lineages from most expressing neural progenitor cells by a mechanism resembling developmental binary cell-fate switching. PMID: 21624811
26. suggesting that OLIG2 function in pediatric gliomas is cell lineage dependent PMID: 21193945
27. analysis of conserved and non-conserved functional elements at the Olig1 and Olig2 locus PMID: 21206754
28. 1p19q whole loss was also significantly associated with Olig2 overexpression, but was never observed in tumors overexpressing p53 protein in oligodendroglial tumors PMID: 20081802
29. Analysis of 180 primary, metastatic, and non-neural human tumors shows OLIG2 is highly expressed in all diffuse gliomas. Immunohistochemistry and microarray analyses demonstrate higher OLIG2 in anaplastic oligodendrogliomas versus glioblastomas. PMID: 15198128
30. Overexpression of OLIG2 was not only found in oligodendroglioma samples and normal neural tissue but also in a wide spectrum of malignant cell lines including leukemia, non-small cell lung carcinoma, melanoma, and breast cancer cell lines. PMID: 16103065
31. Olig1 and Olig2 transcription factors in the human central nervous system are important not only for differentiation of the oligodendrocyte lineage, but they may also have a role in neural cell specification. PMID: 16267213
32. Transcriptional regulation of transgenic Olig2 is involved in segregation of motoneuron precursor neuroblasts in the developing mouse spinal cord. PMID: 16469306
33. A novel function of OLIG2 is to suppress glial tumor cell growth via cyclin-dependent kinase inhibitor p27. PMID: 16554441
34. Findings show a general requirement for Olig2 function in glial cell development and highlight further roles for Olig transcription factors in neural progenitor cells. PMID: 16682644
35. Data provide strong convergent evidence that variation in OLIG2 confers susceptibility to schizophrenia alone and as part of a network of genes implicated in oligodendrocyte function. PMID: 16891421
36. Mutations in OLIG1 and OLIG2 are not likely to be associated with this subgroup of hypomyelinating disorders. PMID: 17171653
37. OLIG2 expression was predominant over ID2 expression in oligodendroglial tumors, while ID2 expression was predominant over OLIG2 expression in astrocytic tumors. PMID: 17431671
38. No significan correlation was found between proliferation index in pilocytic astrocytomas and Olig-2 expression. PMID: 17690840
39. IL-13Ralpha2 and Olig2 have been identified and confirmed to be interesting candidate genes whose differential expression likely plays a role in malignant progression of astrocytomas PMID: 17917751
40. absence of OLIG2 mutation in three PMLD patients presenting with a phenotype characterized by severe hypomyelination and motor neuron dysfunction PMID: 17918228
41. The SNP rs762178 in OLIG2 seems to be a potential candidate in altering risk for schizophrenia in the Chinese Han population. PMID: 17934761
42. OLIG2 suppresses the motile phenotype of glioblastoma cells by activating RhoA. PMID: 17951409
43. We found that genetic polymorphisms in CNP (rs2070106) and OLIG2 (rs1059004 and PMID: 17964117
44. analysis of Olig2 immunohistochemistry in microcystic areas might therefore be useful for the differential diagnosis of pilocytic astrocytoma and diffuse astrocytomas . PMID: 18312545
45. Olig2-immunohistochemistry is useful and potentially more reliable than the epithelial membrane antigen-immunohistochemistry for the diagnosis of ependymoma PMID: 18552083
46. Olig2-induced neural stem cell differentiation involves downregulation of Wnt pathway. PMID: 19093005
47. Significant evidence for association of psychotic symptoms within cases was identified for two SNPs, rs762237 and rs2834072. PMID: 19477230
48. transplantation of human neural stem cells genetically modified to express Olig2 transcription factor improved locomotor recovery and enhanced myelination in a rat contusive spinal cord injury model. PMID: 19772605

Show More

Hide All

HGNC: 9398

OMIM: 606386

KEGG: hsa:10215

STRING: 9606.ENSP00000331040

UniGene: Hs.176977